Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109369638B details a green, high-yield synthesis of dasatinib intermediates using heteropolyacid catalysis, offering significant cost reduction in API manufacturing.
Patent CN1993369A details a cost-effective Nickel-catalyzed route for Terbinafine intermediates, offering significant supply chain advantages and high-purity manufacturing capabilities.
Patent CN106866557A offers a green copper-catalyzed route for high-purity triazole intermediates, reducing cost and lead time for pharmaceutical manufacturing.
Patent CN103641937A reveals green ethylation using diethyl carbonate. Achieve high purity pharmaceutical intermediates with reduced toxic waste and scalable production.
Patent CN119219504B reveals mild hydrazine route for triarylmethane skeletons offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112533908B reveals a high-yield Cariprazine synthesis. Discover cost-effective manufacturing and supply chain advantages for this key API intermediate.
Novel one-pot synthesis for neuraminidase inhibitors using acetic acid catalyst. Enhances yield and purity for pharmaceutical supply chains.
Patent CN102477000A details a streamlined 5-step synthesis for beta-2 agonists, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN102127003B details a novel organocatalytic route for Tamiflu intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
This novel semi-synthetic route enhances yield and purity significantly. It reduces operational costs in API manufacturing for global supply chains effectively.
Patent CN109384744A reveals a solvent-free synthesis route for Quetiapine intermediates. This method ensures high purity and reduces manufacturing complexity for global supply chains.
Novel synthesis route for 5-chloro-2-acyl chlorides thiophene ensures high purity and cost reduction for anticoagulant manufacturing supply chains.
Patent CN111763179A details a novel oxazolidine-based route for paclitaxel side chains, offering high purity, safety, and cost reduction in API manufacturing.
Patent CN102020619B reveals a mild 1,4-addition method for separating Cephalomannine from Taxol, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN109384744A enables direct synthesis of Quetiapine intermediate with high purity. Reduces steps and cost for pharmaceutical manufacturing supply chains globally.
Patent CN1553893A details a novel thionylation process for anticancer adjuvants. Offers scalable routes for high-purity pharmaceutical intermediates with reduced toxicity risks.
Discover the novel Canertinib synthesis via CN103242244A. A streamlined, cost-effective route for high-purity pharmaceutical intermediates suitable for industrial scale-up.
Patent CN102180892A details a novel purification method enhancing purity and yield. This offers significant supply chain stability and cost reduction in API manufacturing.
Novel triazole-linked betulic acid nucleoside conjugates improve solubility and antitumor activity. Scalable synthesis route available for commercial procurement.
Novel patent CN116854610A enables high-purity impurity standards for contrast agent quality control and supply chain stability.